BRISTOL-MYERS SQUIBB COMPANY Investments, Fair Value Disclosure
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Investments, Fair Value Disclosure of $5.12 billion as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:InvestmentsFairValueDisclosure · last filed 2020-05-07
- 2020-03-31: Investments, Fair Value Disclosure $5.12B.
- 2019-12-31: Investments, Fair Value Disclosure $6.01B.
- 2019-09-30: Investments, Fair Value Disclosure $3.24B.
- 2019-06-30: Investments, Fair Value Disclosure $2.44B.
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2020-03-31 | $5.12B 10-Q · filed 2020-05-07 |
| 2019-12-31 | $6.01B 10-Q · filed 2020-05-07 |
| 2019-09-30 | $3.24B 10-Q · filed 2019-10-31 |
| 2019-06-30 | $2.44B 10-Q · filed 2019-07-25 |
| 2019-03-31 | $3.10B 10-Q · filed 2019-04-25 |
| 2018-12-31 | $4.10B 10-K · filed 2020-02-24 |
| 2017-12-31 | $3.94B 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |